SBC Medical Group (SBC) Fundamental Analysis: Revenue, Earnings & Valuation

8.97 / 10

Outperform

Fundamental analysis rates the stock Outperform with a 9/10 score. Liquidity is strong (quick ratio 5.06, current assets 70.7% of total), interest coverage is high (15.6x). Profit‑to‑MV and net‑income‑to‑revenue are bullish, while Asset‑MV and long‑term debt ratios are weaker.

Analysis Checks(7/10)

Profit-MV

Value1.14

Score3/3

Weight62.50%

1M Return6.80%

Net income-Revenue

Value0.54

Score3/3

Weight27.72%

1M Return3.01%

Quick ratio

Value5.06

Score2/3

Weight-0.05%

1M Return-0.01%

Rate of return on total assets (%)

Value21.59

Score3/3

Weight30.70%

1M Return3.12%

Fixed assets turnover ratio

Value10.15

Score1/3

Weight-15.86%

1M Return-2.10%

Long-term debt to working capital ratio (%)

Value0.16

Score1/3

Weight-22.11%

1M Return-2.87%

Annualized return on total assets (%)

Value28.78

Score3/3

Weight30.70%

1M Return3.12%

Interest coverage ratio (EBIT / Interest expense) (%)

Value15.64

Score2/3

Weight-15.36%

1M Return-1.91%

Asset-MV

Value-0.48

Score1/3

Weight22.00%

1M Return2.39%

Current assets / Total assets (%)

Value70.70

Score2/3

Weight-20.23%

1M Return-2.61%

Is SBC fundamentally strong?

SBC scores 8.97/10 on fundamentals and holds a Discounted valuation at present. Backed by its 16.60% ROE, 24.27% net margin, 9.23 P/E ratio, 1.61 P/B ratio, and -26.32% earnings growth, these metrics solidify its Outperform investment rating.